Xenetic Biosciences, Inc.
USD3.09
+0.24 (+8.42%)
CEO
James F. Parslow
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.96
Prev. Close
$2.85
Day Low
$2.74
Day High
$3.09
52W Low
$1.90
52W High
$13.93
Market Cap
$0.01B
Volume
0.04M
| 2,500 |
| $2.17 |
| 5 Jan 2026 | Dastoor Firdaus J. | director | A-Award | Acquired | 2,500 | $2.17 |
| 5 Jan 2026 | Kornberg Roger D. | director | A-Award | Acquired | 2,500 | $2.17 |
| 5 Jan 2026 | Borisenko Grigory G. | director | A-Award | Acquired | 2,500 | $2.17 |
| 13 Dec 2024 | Dastoor Firdaus J. | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | Kornberg Roger D. | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | VINOGRADOV ALEXEY ANDREEVICH | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | Borisenko Grigory G. | director | A-Award | Acquired | 2,500 | $4.24 |
| 21 Jun 2024 | PARSLOW JAMES F | Interim CEO and CFO | A-Award | Acquired | 20,000 | $3.99 |